Results 121 to 130 of about 77,340 (198)

Characterization of secondary bacterial infections in Buruli ulcer disease in Ghana: a focus on antimicrobial resistant Staphylococcus aureus. [PDF]

BMC Infect Dis
Boadi AO, Akenten CW, Thye T, Ackam N, Nkrumah-Appau M, Oppong M, Ahiatrogah DK, Sogbo V, Ayinlooya ENA, Adu-Asiamah CK, Agbavor B, Agbanyo A, Loag W, Khan NA, Berg S, Sylverken AA, May J, Amoako YA, Dekker D, Phillips RO.   +19 more
europepmc   +1 more source

Global Emergence of Buruli Ulcer

EcoHealth, 2019
Jagadesh, Soushieta, Combe, Marine, Couppié, Pierre, Nacher, Mathieu, Gozlan, Rodolphe Elie   +4 more
openaire   +4 more sources

Human-induced pressures and environmental factors drive the distribution of neglected tropical disease Buruli ulcer. [PDF]

Commun Med (Lond)
Aliaga-Samanez A, Cobos-Mayo M, Chevillon C, Dogbe M, Fast KM, Scott ME, Waters K, Receveur JP, Pechal JL, Sandel MW, Jordan HR, Benbow ME, Guégan JF.   +12 more
europepmc   +1 more source

Comparative analysis of Buruli ulcer in Ghana and Côte d'Ivoire: A cross-sectional study. [PDF]

PLoS Negl Trop Dis
Gyamfi E, Dogbe M, Sarpong-Duah M, Kyei-Baffour ES, Boateng KO, Asante DA, Ayelazuno JA, Quaye C, Afouda AA, Mosi L.   +9 more
europepmc   +1 more source

Accelerating vaccine research and development for skin neglected tropical diseases: A case for leishmaniasis, leprosy, and Buruli ulcer. [PDF]

PLoS Negl Trop Dis
Wang H, Novais FO, Gómez MA, Muhi S, de Oliveira CI, Pham TT, Vermaak S, VALIDATE Network Skin NTDs Working Group, Reljic R.   +8 more
europepmc   +1 more source

High-dose rifampicin and clarithromycin for 4 weeks versus standard-dose rifampicin and clarithromycin for 8 weeks to treat Buruli ulcer: An open-label, individually randomized, controlled trial in Ghana. [PDF]

PLoS Negl Trop Dis
Agbanyo A, Amoako YA, Opondo C, Oppong MN, Asante-Poku A, Novignon J, Tuffour J, Mintah IS, Tuwor RD, Ahiatrogah DK, Akuffo RA, Gborglah M, Mosweu I, Pitt C, Allen E, Walker SL, Yeboah-Manu D, Marks M, Phillips RO, SHARP Collaboration.   +19 more
europepmc   +1 more source

In Silico Identification of Potential Biomarker-Binding Proteins for Noninvasive Diagnosis of Buruli Ulcer Disease. [PDF]

Bioinform Biol Insights
Akanko EA, Agoni C, Hanson G, Mensah-Brown HE, Kan-Dapaah K, Hayford CF, Adams CF, Mosi L, Kwofie SK.   +8 more
europepmc   +1 more source

Epidemiology of Buruli Ulcer in Victoria, Australia, 2017-2022. [PDF]

Emerg Infect Dis
Ravindran B, Hennessy D, O'Hara M, Tay EL, Banuve RS, McVernon J, Carville K.   +6 more
europepmc   +1 more source

Repurposing drugs to advance the treatment of Buruli ulcer. [PDF]

Antimicrob Agents Chemother
Singh S, Yotsu R, Nuremberger E, Srivastava S.   +3 more
europepmc   +1 more source

Erratum for Singh et al., "Repurposing drugs to advance the treatment of Buruli ulcer". [PDF]

Antimicrob Agents Chemother
Singh S, Yotsu R, Nuermberger E, Srivastava S.   +3 more
europepmc   +1 more source